Your session is about to expire
← Back to Search
Ketorolac for Ovarian Cancer
Study Summary
This trial is testing whether ketorolac can help treat ovarian cancer by looking at how it affects cancer cells in the body.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- You are allergic to NSAIDs.My cancer is not ovarian but has spread to the ovaries.I am suspected to have ovarian, fallopian tube, or peritoneal cancer and am planning to undergo surgery to remove it.My blood tests show enough neutrophils and platelets.I do not have any known bleeding disorders.My health conditions are stable and under control.I am currently on medication to prevent blood clots.My kidney function is impaired with high creatinine or low clearance.My liver tests are within the required range.I do not have an active stomach ulcer.I am not currently experiencing any bleeding.I haven't taken NSAIDs like ketorolac 7 days before my surgery.You have a medical condition that makes you at high risk for complications from taking ketorolac, according to your doctor.I have borderline ovarian cancer with fluid in my abdomen.My cancer diagnosis was confirmed during surgery.I am currently experiencing active bleeding or am at high risk for bleeding.You are not allergic to NSAIDs (non-steroidal anti-inflammatory drugs).I am a woman aged 18 or older.Your kidney function, measured by a blood test called serum creatinine, should be within a certain range.I am mostly self-sufficient and can carry out daily activities.My ovarian cancer is borderline without fluid buildup in my abdomen.I am not experiencing any bleeding after surgery.I had surgery to remove as much cancer as possible.
- Group 1: Ketorolac
- Group 2: Placebo
- All Individual Drugs Already Approved - Therapies where all constituent drugs have already been approved are likely to have better-understood side effect profiles.
- Approved for 5 Other Conditions - This treatment demonstrated efficacy for 5 other conditions.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
What ailments has Ketorolac been demonstrated to alleviate?
"Ketorolac is typically prescribed to treat ocular itching, but can also provide relief from pain and be administered as a nerve block or pupil dilation."
Could you outline any prior research involving the use of Ketorolac?
"At the moment, 38 studies related to Ketorolac are underway. 8 of those projects occupy Phase 3 and 57 trial sites exist across the United States - with a hefty concentration in Los Angeles."
To what extent has recruitment progressed for this study?
"Regrettably, this trial is not currently recruiting. It was inaugurated on October 29th 2015 and modified most recently on the 4th of October 2022. However, there are 697 fallopian tubes cancer clinical trials with open recruitment and 38 studies for Ketorolac that require participants."
Is enrollment in this experiment still open to the public?
"According to records hosted on clinicaltrials.gov, the recruiting period for this medical research has concluded. This study debuted on October 29th 2015 and had its most recent update done in October 4th 2022. Despite the fact that patients are no longer being accepted, 735 other studies are still inviting participants right now."
Share this study with friends
Copy Link
Messenger